v3.26.1
Revenue Recognition and Accounts Receivable - Schedule of Net Sales by Product Category and Reporting Segment (Detail) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 210,933 $ 203,121 $ 407,641 $ 396,767
Change 3.80%   2.70%  
Therapeutic Solutions [Member]        
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 64,152 62,573 $ 121,926 117,623
Change 2.50%   3.70%  
Spinal Implants, Biologics, and Enabling Technologies [Member]        
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 109,091 107,251 $ 215,169 216,037
Change 1.70%   (0.40%)  
Global Spine [Member]        
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 173,243 169,824 $ 337,095 333,660
Change 2.00%   1.00%  
Global Limb Reconstruction [Member]        
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 37,690 $ 33,297 $ 70,546 $ 63,107
Change 13.20%   11.80%